Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus
Age and Ageing · 01.05.2024 · 53 (5)
DOI: 10.1093/ageing/afae090 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Age and Ageing, online erschienen am 05.05.2024. Verfasst von Archie E Belfield und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Sarcopenia, Hand Strength, Diabetes Mellitus, Type 2, Adiposity. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health, Care Research (NIHR) Leicester Biomedical Research Centre (BRC).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The updated European Working Group on Sarcopenia in Older People (EWGSOP2) recommends handgrip strength (HGS) and the chair stand test (CST) to assess muscle strength, with the CST being a convenient proxy for lower limb strength. However, adiposity may differentially influence these strength criteria and produce discrepant sarcopenia prevalence.
Objective
To determine the prevalence of sarcopenia using HGS or the CST, and to investigate the associations between these strength criteria and adiposity in adults with type 2 diabetes mellitus.
Methods
The EWGSOP2 definition was used to assess the prevalence of probable (low muscle strength), confirmed (plus low muscle mass) and severe (plus poor physical performance) sarcopenia. Linear regression models were used to study the association between different measures of muscle strength and adiposity.
Results
We used data from 732 adults with type 2 diabetes mellitus (35.7% female, aged 64 ± 8 years, body mass index 30.7 ± 5.0 kg/m2). Using the CST compared with HGS produced a higher prevalence of probable (31.7% vs. 7.1%), confirmed (5.6% vs. 1.6%) and severe (1.0% vs. 0.3%) sarcopenia, with poor agreement between strength criteria to identify probable sarcopenia. CST performance, but not HGS, was significantly associated with all measures of adiposity in unadjusted and adjusted models.
Conclusions
Higher levels of adiposity may impact CST performance, but not HGS, resulting in a higher prevalence of sarcopenia in adults with type 2 diabetes mellitus. Consideration should be paid to the most appropriate measure of muscle function in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.
- NIHR Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK.
- Diabetes Research Centre, University of Leicester, Leicester, UK.
- Leicester Diabetes Centre, University Hospitals of Leicester, Leicester, UK.
- NIHR Biomedical Research Centre, Birmingham, UK.
- The Hanning Sleep Laboratory, University Hospitals of Leicester NHS Trust, Leicester, UK.
Förderung
- National Institute for Health
- Care Research (NIHR) Leicester Biomedical Research Centre (BRC)
Zitieren
APA
Belfield, A. E., Wilkinson, T. J., Henson, J., Sargeant, J. A., Breen, L., Hall, A. P., Davies, M. J., & Yates, T. (2024). Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus. Age and Ageing, 53(5). https://doi.org/10.1093/ageing/afae090
Vancouver
Belfield AE, Wilkinson TJ, Henson J, Sargeant JA, Breen L, Hall AP, et al. Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus. Age and Ageing. 2024;53(5). doi:10.1093/ageing/afae090
BibTeX
@article{Belfield2024,
author = {Belfield, Archie E and Wilkinson, Thomas J and Henson, Joseph and Sargeant, Jack A and Breen, Leigh and Hall, Andrew P and Davies, Melanie J and Yates, Thomas},
title = {Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus},
journal = {Age and Ageing},
year = {2024},
volume = {53},
number = {5},
doi = {10.1093/ageing/afae090}
}
EUVIMED